GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 768 filers reported holding GLAXOSMITHKLINE PLC in Q4 2017. The put-call ratio across all filers is 1.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $48,000 | -12.7% | 1,350 | 0.0% | 0.07% | +4.6% |
| Q3 2017 | $55,000 | -87.7% | 1,350 | -87.0% | 0.06% | -80.9% |
| Q2 2017 | $446,000 | -64.2% | 10,350 | -65.0% | 0.34% | -56.6% |
| Q1 2017 | $1,247,000 | +9.5% | 29,567 | 0.0% | 0.79% | +14.1% |
| Q4 2016 | $1,139,000 | -26.8% | 29,567 | -18.0% | 0.69% | -21.0% |
| Q3 2016 | $1,556,000 | +9.3% | 36,067 | +9.8% | 0.87% | +3.1% |
| Q2 2016 | $1,424,000 | +8.8% | 32,859 | +1.8% | 0.85% | +21.2% |
| Q1 2016 | $1,309,000 | -8.2% | 32,278 | -8.6% | 0.70% | -5.5% |
| Q4 2015 | $1,426,000 | -2.1% | 35,329 | -6.7% | 0.74% | +3.1% |
| Q3 2015 | $1,456,000 | -11.0% | 37,879 | -3.6% | 0.72% | -8.1% |
| Q2 2015 | $1,636,000 | -9.8% | 39,290 | 0.0% | 0.78% | -11.0% |
| Q1 2015 | $1,813,000 | +8.0% | 39,290 | 0.0% | 0.88% | +11.3% |
| Q4 2014 | $1,679,000 | -12.0% | 39,290 | -5.3% | 0.79% | -9.3% |
| Q3 2014 | $1,907,000 | – | 41,480 | – | 0.87% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |